Educational session: ‘Benign or malignant?’
Morphologic and clinical features in distinguishing benign from malignant lymphoid
proliferations. Nancy Lee Harris
Immunoglobulin immunohistochemistry in distinguishing benign from malignant lymphoid
proliferations. Peter Isaacson
Clonality testing in haematopathology: Potentials and problems. Han van Krieken
Benign vs malignant lymphoid lesions in the skin. Rein Willemze
MGUS, myeloma and amyloidosis. Robert McKenna
Bone Marrow Symposium: From molecular and histopathological bone marrow
studies to therapy
Review from Cleveland meeting: Plasma cell myeloma and other plasma cell neoplasms -
exciting new facts about an old disease. Falko Fend
Blasts in the bone marrow: Information from bone marrow smears, bone marrow biopsy and
flow cytometry. Robert McKenna
Myeloproliferative neoplasms. Recent advances in pathogenesis. Andy Chase
Myelodysplastic syndrome: from bone marrow studies to new therapies. Eva Hellström-
Lindberg
Impact of new prognostic markers on treatment decisions in acute myeloid leukaemia.
Hartmut Döhner
Lymphoma Symposium: Early Events in Lymphomagenesis
Early molecular events in lymphomagenesis. Bertrand Nadel
Monoclonal B-cell lymphocytosis. Paolo Ghia
Clinical impact of early lymphoma lesions. Eva Kimby
Role of inflammation and autoimmunity in lymphoma. Eva Baecklund
Early lymphomagenesis in T-cell neoplasms. Ahmet Dogan
New antibodies: The human protein atlas project. Fredrik Pontén
Diagnostic imaging of proteins and their interactions in pathology. Ulf Landegren
|
